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Abstract
Introduction Systemic inflammatory response syndrome (SIRS)
is a frequent condition after cardiopulmonary bypass (CPB) and
makes conventional biological tests fail to detect postoperative
sepsis. Biphasic waveform (BPW) analysis is a new biological
test derived from activated partial thromboplastin time that has
recently been proposed for sepsis diagnosis. The aim of this
study was to investigate the accuracy of BPW to detect sepsis
after cardiac surgery under CPB.
Methods We conducted a prospective study in American
Society of Anesthesiologists' (ASA) physical status III and IV
patients referred for cardiac surgery under CPB. Procalcitonin
(PCT) and BPW were recorded before surgery and every day
during the first week following surgery. Patients were then
divided into three groups: patients presenting no SIRS, patients
presenting with non-septic SIRS and patients presenting with
sepsis.
Results Thirty two patients were included. SIRS occurred in 16
patients (50%) including 5 sepsis (16%) and 11 (34%) non-
septic SIRS. PCT and BPW were significantly increased in
SIRS patients compared to no SIRS patients (0.9 [0.5-2.2] vs.
8.1 [2.0-21.3] ng/l for PCT and 0.10 [0.09-0.14] vs. 0.29 [0.16-
0.56] %T/s for BPW; P < 0.05 for both). We observed no
difference in peak PCT value between the sepsis group and the
non-septic SIRS group (8.4 [7.5-32.2] vs. 7.8 [1.9-17.5] ng/l; P
= 0.67). On the other hand, we found that BPW was
significantly higher in the sepsis group compared to the non-
septic SIRS group (0.57 [0.54-0.78] vs. 0.19 [0.14-0.29] %T/
s; P < 0.01). We found that a BPW threshold value of 0.465%T/
s was able to discriminate between sepsis and non-septic SIRS
groups with a sensitivity of 100% and a specificity of 93% (area
under the curve: 0.948 +/- 0.039; P < 0.01). Applying the
previously published threshold of 0.25%T/s, we found a
sensitivity of 100% and a specificity of 72% to discriminate
between these two groups. Neither C-reactive protein (CRP)
nor PCT had significant predictive value (area under the curve
for CRP was 0.659 +/- 0.142; P = 0.26 and area under the
curve for PCT was 0.704 +/- 0.133; P = 0.15).
Conclusions BPW has potential clinical applications for sepsis
diagnosis in the postoperative period following cardiac surgery
under CPB.
Introduction
Cardiac surgery using cardiopulmonary bypass (CPB)
induces a non-specific acute inflammatory response. The
pathophysiology of this inflammatory response is not com-
pletely understood [1,2]. Different mechanisms seem to be
involved such as surgical trauma, transfusion, blood loss and
hypothermia. CPB can activate the immune system via leuco-
cyte interactions with the foreign surfaces of the CPB circuitsPage 1 of 10
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endotoxin release may also participate [1]. The term systemic
inflammatory response syndrome (SIRS) has been proposed
by the American College of Chest Physicians/Society of Criti-
cal Care Medicine Consensus Conference Committee to
define a non-specific generalized inflammatory process inde-
pendently from any causative factor [3].
Because of this non-specific SIRS situation, conventional clin-
ical and biological tests fail to detect postoperative infection in
the cardiac surgery setting. This can delay the diagnosis and
treatment of sepsis and may increase postoperative mortality
and morbidity [4]. Existing biological markers such as C-reac-
tive protein (CRP) and procalcitonin (PCT) have been studied
after CPB [5,6]. Serum CRP values increase during the post-
operative period after cardiac surgery even in the absence of
infection [7] and even if serum PCT seems to be a valuable
marker of sepsis, its accuracy remains debatable [8,9] and its
cost may be of concern.
In 1997, Downey and colleagues first described an abnormal-
ity in the optical transmission of the activated partial thrombo-
plastin time (aPTT) [10,11]. This biphasic waveform (BPW)
optical signal is related to the rapid formation of calcium-
dependant complexes between very low-density lipoprotein
and CRP [12]. Recently, several studies have suggested that
BPW analysis is an easy, rapid and cost-effective tool for the
diagnosis and prognosis assessment of severe sepsis
patients in the intensive care unit (ICU) [13-15].
Kinetics and diagnostic value of BPW in the postoperative
period following cardiac surgery under CPB have never been
studied. The aim of this study was: to describe kinetics of
BPW in the postoperative period following cardiac surgery
under CPB; and to test its ability to discriminate patients with




We conducted a single-center prospective study between July
2007 and December 2007. The study protocol was approved
by the institutional research ethics committee (Comité
d'éthique des Hospices Civils de Lyon, Lyon, France). Written
informed consent was obtained from each patient. The eligibil-
ity criteria were as follows: older than 18 years old, elective
open-heart CPB surgery, American Society of Anesthesiology
(ASA) physical status III or IV. Exclusion criteria were: preop-
erative SIRS of any cause (infection, systemic disease), corti-
coidsteroids or non-steroidal anti-inflammatory drug use within
the last seven days before surgery.
Data collection
Demographic data were recorded at inclusion: age, gender,
weight, Simplified Acute Physiology Score II (SAPS II) [16],
European System for Cardiac Operative Risk Evaluation
(EuroSCORE) [17], and ASA physical status, left ventricular
ejection fraction, and beta blocker prescription. Perioperative
data were: type of surgery, aortic clamping time and CPB
duration. Postoperative collected data were: ICU length of
stay, need for inotropic or vasoactive support, postoperative
complication as SIRS or sepsis, need for reoperation, hemor-
rhage (defined as blood loss of up to 4 ml/kg/hour in the post-
operative setting), cardiac tamponade, acute kidney injury
(increased serum creatininemia × 1.5 or urine output <0.6 ml/
kg/h during six consecutive hours [18]), myocardial infarction
(new Q waves of more than 0.04 seconds and 1 mm deep or
a reduction in R waves of more than 25% in at least two con-
tinuous leads of the same territory). Clinical signs as heart rate,
body temperature and respiratory rate were recorded every
hour in the ICU and every eight hours in the step down unit.
Biological data were recorded every day during the seven
days following surgery.
Perioperative management
General anaesthesia was induced using propofol and sufen-
tanil. Muscular relaxant (cisatracurium) was administrated
before tracheal intubation. Anaesthesia was maintained with
inhaled sevoflurane or continuous propofol infusion depending
on the anaesthesiologist choice. All patients had internal jugu-
lar central venous catheter for drug administration and central
venous pressure monitoring. Electrocardiogram with ST mon-
itoring, end-tidal carbon dioxide, arterial blood pressure using
a radial artery catheter, and muscular relaxant monitoring were
always used for monitoring. Pulmonary artery catheter was
inserted when preoperative left ventricular ejection fraction
was less than 0.4 or in the case of a preoperative severe pul-
monary arterial hypertension (systolic pulmonary arterial pres-
sure >50 mmHg). Antibiotic prophylaxis consisted of cefazolin
30 mg/kg at the induction and 1 g every four hours during sur-
gery. Antifibrinolytic therapy (tranexamic acid 30 mg/kg) was
administrated in every patient. Heparin (300 UI/kg) was admin-
istrated before CPB. Myocardial protection was performed
with intermittent infusion of cold crystalloid cardioplegia. Tra-
cheal extubation was performed in the surgical ICU when
patients met all the required criteria according to the referring
physician.
Biologic measurements
Blood samples for biological measurements included white
blood cell counts (WBC), PCT, CRP and BPW. Blood sam-
ples were drawn just after the induction and every morning
during the seven days following surgery.
Serum CRP concentrations were measured using an immuno-
turbidimetric assay on Modular analyser (Roche Diagnostics,
Meylan, France). PCT was measured using the Kryptor PCT
test (Brahms Diagnostica, Berlin, Germany). The aPTT wave
form analysis was performed with the MDA II analyzer
(BioMérieux, Marcy L'Etoile, France). In the aPTT assay, thePage 2 of 10
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tifies an abnormal BPW. BPW signal unit is transmittance per-
centage per second (%T/s).
Diagnosis of SIRS and sepsis
SIRS and sepsis diagnosis were established according to the
American College of Chest Physicians/Society of Critical
Care Medicine Consensus Conference Committee classifica-
tion [3]. SIRS diagnosis requires the presence of two or more
of the following criteria: body temperature above 38°C or
below 36°C; heart rate above 90 beats/min; respiratory rate
above 20 breaths/min or partial pressure of arterial carbon
dioxide below 32 mmHg; leukocytes count above 12 G/L or
below 4 G/L. Sepsis was defined as a SIRS associated to a
documented infection. Pneumonia was defined as SIRS with
infiltrate on chest radiograph and micro-organism isolated in
bronchial secretions.
The final diagnosis of SIRS or sepsis was retrospectively
established by two experts in taking into account the complete
medical data. The experts were not in charge of the patients.
The medical team in charge of the postoperative period was
aware of the complete biological measurements except for
BPW.
Statistical analysis
All data were tested for normality with Shapiro-Wilk test. Data
are reported as mean ± standard deviation or median (inter-
quartile range) when appropriate. Data were analyzed using
nonparametric Mann-Whitney U-test or Wilcoxon test as
appropriate. The time course of CRP, PCT, and BPW concen-
tration were tested by analysis of variance for repeated meas-
ures followed by a Bonferroni post hoc test. Patients were
then divided in to three groups according to the predefined fol-
lowing criterion: patients presenting no postoperative SIRS
(no SIRS group), patients presenting postoperative SIRS
were defined as the SIRS group including patients presenting
with sepsis, and patients presenting with non-septic SIRS.
Receiver operating characteristic (ROC) curves were gener-
ated to test the ability of CRP, PCT, and BPW to discriminate
between sepsis and non-septic SIRS patients varying the dis-
criminating threshold of each parameters and area under the
ROC curves were calculated and compared (MedCalc
8.0.2.0, MedCalc Software, Mariakerke, Belgium). A P value <
0.05 was considered statistically significant. All statistical
analyses were performed using SPSS 13.0 for Windows
(SPSS, Chicago, IL, USA).
Results
Thirty two patients were included in the study. Demographic
data are reported in Table 1. Sixteen patients (50%) did not
present SIRS according to the predefined criteria. Among the
16 SIRS patients (50%), 5 patients (16%) presented with
postoperative sepsis and 11 patients (34%) developed non-
septic SIRS. CRP, PCT, and BPW postoperative evolutions in
the 32 patients are presented in Figure 1. Interestingly, CRP
and PCT were significantly increased at day 1 compared with
baseline.
Figure 1
Box plot showing the evolution of CRP, PCT, and BWP in the studied sam le
sample.  BPW = biphasic waveform; CRP = C-reactive protein; PCT = 
procalcitonin. D0, D1, D2, D3, D4, D5, D6, and D7: Preoperative and 
postoperative day 1, 2, 3, 4, 5, 6, and 7, respectively. * P < 0.05 com-
pared with previous day.Page 3 of 10
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Table 2 describes no SIRS vs. SIRS groups' characteristics.
Length of stay was significantly lower in no SIRS group com-
pared with SIRS group. Table 3 represents peak values for
CRP, PCT and BPW in SIRS and no SIRS patients. We
observed no difference in peak CRP value between no SIRS
and SIRS groups (199 (180 to 264) vs. 240 (237 to 283) mg/
l; P = 0.09) both values being statistically higher than CRP at
baseline (P < 0.001 for both). On the other hand, we found
that PCT and BPW peak values were significantly increased in
SIRS compared with no SIRS (0.9 (0.5 to 2.2) vs. 8.1 (2.0 to
21.3) ng/l for PCT and 0.10 (0.09 to 0.14) vs. 0.29 (0.16 to
0.56) %T/s for BPW; P < 0.05 for both). Both PCT and BPW






Age (years) 72 (62-78)
Weight (kgs) 76 ± 11
Length of stay in the ICU (days) 5 (2-7)
SAPS II score 29 (23-38)
EuroScore 9 ± 3
LVEF <40% (n) 12 (38%)
ASA physical status (III/IV) 22/10
Surgical procedure (n)
- Valvular surgery 15
- Combined surgery 5
- Ascending aorta surgery 10
- CABG 2
CPB length (min) 113 (86-121)
Aortic cross clamping length (min) 82 ± 28
Post operative complications (n)
- Total of patients presenting at least one postoperative complication 18 (56%)
- Non-septic SIRS 11 (34%)
- Sepsis 5 (16%)
- Reoperation 4 (13%)
- Hemorrhage 7 (22%)
- Inotropic support 2 (6%)
- Myocardial infarction 6 (19%)
- AKI requiring RRT 3 (9%)
Death (n) 4 (13%)
Data expressed as mean ± standard deviation, median (interquartile range), or number (percentage).
AKI = acute kidney injury; ASA = American Society of Anesthesiology; CABG = coronary artery bypass grafting; CBP = cardiopulmonary bypass; 
EuroSCORE = European system for cardiac operative risk evaluation; ICU = intensive care unit; LVEF = left ventricular ejection fraction; RRT = 
renal replacement therapy; SAPS II = simplified acute physiology score; SIRS = systemic inflammatory response syndrome.Page 4 of 10
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Among the 16 patients presenting with SIRS, five (31%)
patients were classified as sepsis patients. Aetiology for sep-
sis was pneumonia in all patients. Its diagnosis occurred three
(2.25 to 3.75) days after surgery. Sepsis and non-septic SIRS
patient's characteristics are reported in Table 4. We observed
no difference in peak CRP value between sepsis and non-sep-
tic SIRS groups (270 (223 to 279) vs. 239 (237 to 270) mg/
l; P = 0.37) and no difference in peak PCT value between sep-
sis and non-septic SIRS groups (8.4 (7.5 to 32.2) vs. 7.8 (1.9
to 17.5) ng/l; P = 0.67; Table 3). On the other hand, we found
that BPW was significantly higher in sepsis compared with
non-septic SIRS (0.57 (0.54 to 0.78) vs. 0.19 (0.14 to 0.29)
%T/s; P < 0.01).
Table 2
no SIRS vs SIRS patients characteristics





Male/female 12/4 13/3 0.986
Age (years) 74 (69-77) 69 (60-79) 0.46
ASA physical status (III/IV) 14/2 8/8 0.057
EuroSCORE 9 ± 3 9 ± 4 0.963
LVEF <40% 7 (44%) 5 (31%) 0.693
Perioperative beta blockers 4 (25%) 3 (27%) 0.74
Baseline biologic measurements
- WBC (G/L) 7.6 ± 2.5 7.6 ± 2.1 0.817
- CRP (mg/L) 1.8 (1.1-5.7) 6.7 (2.2-14.3) 0.016
- PCT (ng/L) 0.07 (0.06-0.1) 0.09 (0.09-0.20) 0.052
- BPW (%T/s) 0.02 ± 0.02 0.03 ± 0.02 0.423
SAPS II score 29 (23-30) 32 (23-43) 0.221
Surgical procedure
- Valvular surgery 5 (30%) 10 (62%) _
- Combined surgery 2 (13%) 3 (19%)
- Ascending aortia surgery 7 (44%) 3 (19%)
- CABG 2 (13%) 0
CPB duration (min) 106 (81-116) 120 (92-146) 0.09
Aortic cross clamping time (min) 75 ± 25 88 ± 31 0.187
Length of stay in the ICU (days) 2 (2-4) 5 (4-15) 0.006
Post operative complication
- Reoperation 0 4 (25%) 0.11
- Hemorrhage 2 (13%) 5 (31%) 0.42
- Tamponade 0 2 (13%) 0.44
- Inotropic support 1 (6%) 5 (31%) 0.17
- Myocardial infarction 0 1 (6%) 0.97
- AKI requiring RRT 0 3 (19%) 0.22
Death (n) 0 4 (25%) 0.11
Data are expressed as mean ± standard deviation, median (interquartile range), or number (percentage).
AKI = acute kidney injury; ASA = American Society of Anesthesiology; BPW = biphasic waveform; CABG = coronary artery bypass grafting; CPB 
= cardiopulmonary bypass; CRP = C-reactive protein; EuroSCORE = European system for cardiac operative risk evaluation; ICU = intensive care 
unit; LVEF = left ventricular ejection fraction; PCT = procalcitonin; RRT = renal replacement therapy; SAPS II = simplified acute physiology score; 
SIRS = systemic inflammatory response syndrome; WBC = white blood cell.Page 5 of 10
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septic SIRS in the postoperative period following cardiac 
surgery
We found that a BPW threshold value of 0.465%T/s was able
to discriminate between sepsis and non-septic SIRS with a
sensitivity of 100% and a specificity of 93% (area under the
curve: 0.948 ± 0.039; P < 0.01) Applying the previously pub-
lished threshold of 0.25%T/s, we found a sensitivity of 100%
and a specificity of 72% to discriminate between these two
groups. Neither CRP nor PCT had significant predictive (area
under the curve for CRP was 0.659 ± 0.142; P = 0.26 and
area under the curve for PCT was 0.704 ± 0.133; P = 0.15).
Discussion
This is the first study to focus on the perioperative kinetics of
BPW in patients undergoing cardiac surgery under CPB. Our
results show that postoperative BPW values have the poten-
tial to discriminate between sepsis and non-septic SIRS in this
setting. A BPW threshold value of 0.465%T/s was able to dis-
criminate between sepsis and non-septic SIRS with a sensitiv-
ity of 100% and a specificity of 93% (area under the curve:
0.948 ± 0.039; P < 0.01)
CPB induces a non-specific acute inflammatory response.
Because of this non-specific SIRS situation, conventional clin-
ical and biological tests fail to accurately detect infection in the
postoperative period following cardiac surgery, inducing a
delay in the diagnosis and treatment of postoperative sepsis.
This issue is critical because mortality in sepsis remains high
and because it has been demonstrated that early therapeutic
intervention can improve prognosis [4]. On the other hand,
indiscriminate use of antibiotics in all SIRS patients would lead
to the development of resistant strains and increase toxicity
and costs. This explains why it is of major importance to
explore tools that can accurately discriminate between SIRS
and sepsis in this setting.
Existing biological markers such as CRP and PCT have been
studied after CPB [5,6]. Serum CRP values are not specific
and have been shown to increase in the postoperative period
following cardiac surgery even in the absence of SIRS [7]. Our
data are consistent with this finding because CRP values were
significantly increased in the no SIRS group compared with
baseline. Moreover, the increase in CRP was not different
between no SIRS and SIRS patients in our study. Serum PCT
seems to be a valuable marker of sepsis but its accuracy
remains debated in the postoperative period following cardiac
surgery under CPB [8,9] and its cost may be of concern. In our
study, we found that PCT was significantly increased after
CPB but we found that this increase was significantly higher
in SIRS group than in no SIRS group. However, PCT failed to
discriminate between sepsis and non-septic SIRS patients in
the present study.
The BPW has been proposed as a new tool for infection
detection. Chopin and colleagues have demonstrated that
BPW was more sensitive and more specific than PCT for the
diagnosis of sepsis in the ICU [13] and more recently, Zaka-
riah and colleagues have suggested that a combined evalua-
tion with PCT would increase BPW specificity in sepsis
identification [15]. The BPW is caused by calcium-dependent
formation between lipoproteins and CRP [12]. The very low-
density lipoprotein components from patients with BPW
increase prothrombinase activity [19]. The BPW lasts two to
three days and precedes the diagnosis of overt disseminated
intravascular coagulation by 2.8 days on average [10,11] and
could be a maladaptive consequence of the host haemostatic/
endothelial responses [20-22]. The presence of an abnormal-
ity in the waveform pattern is independent of the aPTT clotting
Table 3
Peak value for CRP, PCT, and BPW according to the group
No SIRS (n = 16) SIRS (n = 16) P value
Peak CRP (mg/L) 199 (180-264) 240 (237-283) 0.09
Peak PCT (ng/L) 0.9 (0.5-2.2) 8.1 (2.0-21.3) 0.04
Peak BPW (%T/s) 0.10 (0.09-0.14) 0.29 (0.16-0.56) 0.03
SIRS group (n = 16)
SIRS (n = 11) Sepsis (n = 5)
Peak CRP (mg/L) 239 (237-270) 270 (223-279) 0.37
Peak PCT (ng/L) 7.8 (1.9-17.5) 8.4 (7.5-32.2) 0.67
Peak BPW (%T/s) 0.19 (0.14-0.29) 0.57 (0.54-0.78) 0.003
Data are presented as median (interquartile range).
BPW = biphasic waveform; CRP = C-reactive protein; PCT = procalcitonin; SIRS = systemic inflammatory response syndrome.Page 6 of 10
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factor deficiencies. Downey and colleagues [10] and Toh and
colleagues [12] have shown that the BPW is not a surrogate
marker for CRP or very low-density lipoprotein and provides
additional information.
The BPW analysis is easy, and represents no additional cost
compared with usual hemostasis tests that are preformed daily
in the postoperative period following cardiac surgery. For
instance, at our institution, a routine charge for an aPTT test is
$7, a CRP test costs $9, and a PCT test costs $30 (US dol-
lars).
In the present study, we found that in the whole population the
BPW was significantly increased during the first 48 hours fol-
lowing cardiac surgery compared with baseline (Figure 1).
However, we observed no significant increase in the BPW in
no SIRS patients whereas the increase in the BPW was sig-
nificant in SIRS patients (Figure 2). This is similar to what was
observed for PCT [23] and different from what was found for
Table 4
Non septic SIRS vs. septic patients' characteristics





Male/female 8/3 5/0 0.55
Age (years) 69 ± 10 61 ± 24 0.37
ASA physical status (III/IV) 7/4 2/3 0.72
Length of stay in the ICU (days) 5 (3-6) 14 (8-18) 0.26
SAPS II 34 (27-42) 23 (19-50) 0.76
EuroSCORE 9 ± 4 8 ± 1 0.67
LVEF <50% 3 (27%) 2 (40%) 0.95
Baseline biologic measurements
- WBC (G/L) 7.6 ± 2.4 6.9 ± 1.0 0.59
- CRP (mg/L) 6.4 (2.4-11.1) 10.9 (1.7-18.3) 0.96
- PCT (ng/L) 0.09 (0.08-0.18) 0.09 (0.07-0.20) 1
- BPW (%T/s) 0.02 ± 0.02 0.04 ± 0.03 0.27
Surgical procedure (n)
- Valvular surgery 7 (63%) 3 (60%)
- Combined surgery 2 (18%) 1 (20%)
- Ascending aorta surgery 2 (18%) 1 (20%)
- CABG 0 0
CPB duration (min) 118 (90-120) 139 (103-208) 0.31
Aortic cross clamping time (min) 84 ± 27 99 ± 39 0.39
Post operative complications (n)
- Reoperation 1 (9%) 3 (60%) 0.12
- Hemorrhage 2 (18%) 3 (60%) 0.27
- Tamponade 0 2 (40%) 0.15
- Inotropic support 3 (27%) 2 (40%) 0.95
- Myocardial infarction 0 1 (20%) 0.68
- AKI requiring RRT 1 (9%) 2 (40%) 0.43
Death (n) 2 (18%) 2 (40%) 0.75
Data are expressed as mean ± standard deviation, median (interquartile range), or number (percentage).
AKI = acute kidney injury; ASA = American Society of Anesthesiology; BPW = biphasic waveform; CABG = coronary artery bypass grafting; CPB 
= cardiopulmonary bypass; CRP = C-reactive protein; EuroSCORE = European system for cardiac operative risk evaluation; ICU = intensive care 
unit; LVEF = left ventricular ejection fraction; PCT = procalcitonin; RRT = renal replacement therapy; SAPS II = simplified acute physiology score; 
SIRS = systemic inflammatory response syndrome.Page 7 of 10
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and no SIRS groups (Figure 2). More interestingly, when anal-
ysis was limited to SIRS group, we found that the increase in
the BPW was significantly higher in sepsis patients compared
with non-septic SIRS patients (Figure 3). At the same time, we
observed no difference in PCT evolutions between sepsis
patients and non-septic SIRS patients (Figure 3).
Whereas BPW was influenced by SIRS occurrence, its value
remained below the existing infection thresholds in the no
SIRS group. In the non-septic SIRS patients, the maximal
value for BPW was 0.15 (0.12 to 0.25) %T/s on day 2
whereas infection threshold in ICU has been shown to be
around 0.25%T/s [13]. On the other hand, every septic patient
had BPW peak value above 0.25%T/s [13]. Consequently, we
found that the best threshold value for BPW (i.e. threshold
allowing for the best sensitivity and specificity) in the present
setting was 0.465%T/s. This is probably related to the fact
that BPW was significantly increased in non-septic SIRS
patients. Consequently, the cut-off value for BPW in the post-
operative period following cardiac surgery under CPB may be
higher than the cut-off value used in conventional ICU.
Study limitations
In the present study we did not include patients undergoing
'off-pump' cardiac surgery and no conclusion can be drawn
regarding this population. However, cardiac surgery under
CPB is the most challenging situation for postoperative sepsis
diagnosis. Further studies will have to focus on off-pump car-
diac surgery. An ideal marker of sepsis should be beneficial
when employed in medical decision making. It remains to be
determined what specific mechanism in sepsis produces an
abnormal BPW and if the BPW has reliable clinical utility for
determining risk, prognosis or treatment in the present setting.
We only studied 32 patients. This may not be enough to
detect any statistically significant difference in peak CRP val-
ues as it is observed between the no SIRS and SIRS group.
Further studies should include a larger number of patients to
be conclusive.
Moreover, all of the sepsis patients in our study presented with
pneumonia. Lungs are known to be a very good source of
thromboplastin and this may explain part of our findings. Con-
sequently, whether the BPW presents the same kinetics in
other forms of lung injury (such as acid aspiration or smoke
inhalation) or in other forms of sepsis (such as peritonitis) will
need to be further explored.
Finally, a limitation of all studies on sepsis markers is that there
is no gold standard to compare with. A list of potential signs
and symptoms of sepsis was provided in the Sepsis Defini-
tions Conference but none alone is specific for sepsis. How-
ever, this limitation applies to any other previously published
studies on sepsis diagnosis.
Figure 2
Box plot showing the evolution of CRP, PCT, and BWP in SIRS and No SIRS groups
SIRS groups.  BPW = biphasic waveform; CRP = C-reactive protein; 
PCT = procalcitonin; SIRS = systemic inflammatory response syn-
drome. D0, D1, D2, D3, D4, D5, D6, and D7: Preoperative and postop-
erative day 1, 2, 3, 4, 5, 6, and 7, respectively. * P < 0.05 compared 
with previous day.Page 8 of 10
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The diagnosis of early sepsis in CPB surgery postoperative
condition is challenging. Usual biological test are often dis-
torted by the occurrence of non-septic SIRS. In our experi-
ence, a BPW threshold value of 0.465%T/s was able to
discriminate between sepsis and non-septic SIRS patients
with a sensitivity of 100% and a specificity of 93% (area under
the curve: 0.948 ± 0.039; P < 0.01). Consequently, the BPW
seems to be an interesting marker for sepsis diagnosis in the
postoperative period following cardiac surgery under CPB.
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Key messages
- Postoperative increase in BPW is significantly higher in 
patients with postoperative SIRS compared with 
patients with no postoperative SIRS.
- Postoperative increase in BPW is significantly higher in 
patients with postoperative sepsis compared with 
patients with non-septic postoperative SIRS.
- A BPW threshold value of 0.465%T/s was able to dis-
criminate between sepsis and non-septic SIRS patients 
with a sensitivity of 100% and a specificity of 93% (area 
under the curve: 0.948 ± 0.039; P < 0.01).
- A routine charge for an aPTT test is $7, a CRP test costs 
$9, and a PCT test costs $30 at our institution.
- BPW seems to be an interesting marker for sepsis diagno-
sis in the postoperative period following cardiac surgery 
under CPB.
Figure 3
Box plot showing the evolution of CRP, PCT, and BWP in sepsis and N n septic SIRS groups
Non septic SIRS groups.  BPW = biphasic waveform; CRP = C-reac-
tive protein; PCT = procalcitonin; SIRS = systemic inflammatory 
response syndrome. D0, D1, D2, D3, D4, D5, D6, and D7: Preopera-
tive and postoperative day 1, 2, 3, 4, 5, 6, and 7, respectively. * P < 
0.05 compared with previous day.Page 9 of 10
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